Spartan Bioscience Inc

$75,000.00 CAD

≈ 12 months of average Canadian pay
Department
National Research Council Canada
Program
CanExport SMEs
Recipient country
Canada
Fiscal year
2020-2021
Agreement period
July 1, 2020 – February 28, 2021
Reference
nrc-cnrc:172-2020-2021-Q2-953830

Published purpose

To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions